Page 3 - Nasdaq Tkno News Today

Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it compare to its peers? We will compare Alpha Teknova to related companies based on the strength of its dividends, risk, profitability, institutional ownership, valuation, earnings and analyst recommendations. Insider and Institutional Ownership 25.5% of […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 publicly-traded companies in the “Diagnostic substances” industry, but how does it contrast to its rivals? We will compare Alpha Teknova to similar companies based on the strength of its risk, earnings, analyst recommendations, profitability, institutional ownership, dividends and valuation. Analyst Recommendations This is a breakdown […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it compare to its rivals? We will compare Alpha Teknova to related businesses based on the strength of its dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Insider and Institutional Ownership 25.5% of […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 public companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Alpha Teknova to similar businesses based on the strength of its institutional ownership, dividends, profitability, analyst recommendations, valuation, risk and earnings. Profitability This table compares Alpha Teknova […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) is one of 39 publicly-traded companies in the “Diagnostic substances” industry, but how does it contrast to its competitors? We will compare Alpha Teknova to related businesses based on the strength of its earnings, profitability, institutional ownership, dividends, risk, valuation and analyst recommendations. Institutional & Insider Ownership 25.5% of […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday, Zacks.com reports. According to Zacks, “Alpha Teknova Inc. is a provider of critical reagents for the development and production of biopharmaceutical products including drug […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) and Lucira Health (NASDAQ:LHDX – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation and institutional ownership. Institutional & Insider Ownership 27.7% of Alpha Teknova shares […]

Alpha Teknova (NASDAQ:TKNO – Get Rating) issued its quarterly earnings data on Tuesday. The company reported ($0.11) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.17) by $0.06, Fidelity Earnings reports. Alpha Teknova updated its FY 2022 guidance to EPS. TKNO stock opened at $14.26 on Friday. The company has a fifty […]